Adenoviral gene transfer of β3 integrin subunit induces conversion from radial to vertical growth phase in primary human melanoma

American Journal of Pathology

Volumn 153, Issue 5, 1998, Pages 1435-1442

  Hsu, Mei Yu ^a   Shih, Daw Tsun ^a,b   Meier, Friedegund E ^a   Van Belle, Patricia ^a   Hsu, Ju Yu ^a,c   Elder, David E ^a   Buck, Clayton A ^a   Herlyn, Meenhard ^a,d  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b BOEHRINGER INGELHEIM PHARMACEUTICALS INC   (United States)

^c SIDNEY KIMMEL CANCER CENTER   (United States)

^d WISTAR INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTEGRIN; VIRUS VECTOR; VITRONECTIN RECEPTOR;

ADENOVIRUS; ARTICLE; CANCER GROWTH; CANCER INVASION; EPIDERMIS; FLOW CYTOMETRY; GENE CONVERSION; GENE OVEREXPRESSION; GENE TRANSFER; HUMAN; HUMAN CELL; MELANOMA; MELANOMA CELL; PRIORITY JOURNAL;

EID: 0031770035     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)65730-6     Document Type: Article

References (54)

1. Clark WH Jr, Elder DE, Guerry D, Epstein MN, Greene MH, Van Horn M: A study of tumor progression: the precursor lesions of superficial spreading and nodular melanoma. Hum Pathol 1984, 15:1147-1165
2. Clark WH Jr: Tumor progression and the nature of cancer. Br J Cancer 1991, 64:631-644
3. Clark WH Jr, Elder DE, Guerry D IV, Braitman LE, Trock BJ, Schultz D, Synnestvedt M, Halpern AC: Model predicting survival in stage I melanoma based on tumor progression. J Natl Cancer Inst 1989, 82:626-627
4. Herlyn M, Thurin J, Balaban G, Bennicelli JL, Herlyn D, Elder DE, Bondi E, Guerry D, Nowell P, Clark WH, Koprowski H: Characteristics of cultured human melanocytes isolated from different stages of tumor progression. Cancer Res 1985, 45:5670-5676
5. Herlyn M, Balaban G, Bennicelli J, Guerry D, Halaban R, Herlyn D, Elder DE, Maul GG, Steplewski Z, Nowell PC, Clark WH Jr, Koprowski H: Primary melanoma cells of the vertical growth phase: similarities to metastatic cells. J Natl Cancer Inst 1985, 74:283-289
6. Herlyn M, Clark WH, Rodeck U, Mancianti ML, Jambrosic J, Koprowski H: Biology of tumor progression in human melanocytes. Lab Invest 1987, 56:461-474
7. Satyamoorthy K, Dejesus E, Linnenbach A, Kraj B, Kornreich DL, Rendle S, Elder DE, Herlyn M: Melanoma cell lines from different stages of progression and their biological and molecular analyses. Melanoma Res 1997, 7:S35-S42
8. Hsu M-Y, Elder DE, Herlyn M: The Wistar melanoma (WM) cell lines. Human Cell Culture, vol. 3: Solid Cancers. Edited by Masters JRW, Palsson B. Kluwer Academic Publishers, Norwell, MA, 1998 (in press)
9. Shih I-M, Elder DE, Hsu M-Y, Herlyn M: Regulation of MelCAM/ MUC18 expression on melanocytes of different stages of tumor progression by normal keratinocytes. Am J Pathol 1994, 145:837-845
10. Rodeck U, Herlyn M, Menssen HD, Furlanetto RW, Koprowski H: Metastatic but not primary melanoma cells grow in vitro independently of exogenous growth factors. Int J Cancer 1987, 40:687-690
11. Rodeck U, Melber K, Kath R, Menssen H-D, Varello M, Atkinson B, Herlyn M: Constitutive expression of multiple growth factor genes by melanoma cells but not normal melanocytes. J Invest Dermatol 1991, 97:20-26
12. Kath R, Jambrosic J, Holland L, Rodeck U, Herlyn M: Development of invasive and growth factor-independent cell variants from primary melanomas. Cancer Res 1991, 51:2205-2211
13. Kath R, Rodeck U, Parmiter A, Jambrosic J, Herlyn M: Growth factor independence in vitro of primary melanoma cells from advanced but not early or intermediate lesions. Cancer Ther Control 1990, 1:179-191
14. Hyne RO: Integrins: versatility, modulation, and signaling in cell adhesion. Cell 1992, 69:11-25
15. Juliano R: Cooperation between soluble factors and integrin-mediated cell anchorage in the control of cell growth and differentiation. Bioessays 1996, 18:911-917
16. Giancotti FG: Integrin signaling: specificity and control of cell survival and cell cycle progression. Curr Opin Cell Biol 1997, 9:691-700
17. Frisch SM, Ruoslahti E: Integrins and anoikis. Curr Opin Cell Biol 1997, 9:701-706
18. Danen EH, Van Muijen GN, Ruiter DJ: Role of integrins as signal transducing cell adhesion molecules in human cutaneous melanoma. Cancer Surv 1995, 24:43-65
19. Mortarini R, Anichini A: From adhesion to signalling: roles of integrins in the biology of human melanoma. Melanoma Res 1993, 3:87-97
20. De Wit PE, Van Muijen GN, De Waal RM, Ruiter DJ: Pathology of malignant melanoma, including new markers and techniques in diagnosis and prognosis. Curr Opin Oncol 1996, 8:143-151
21. Albelda SM, Mette SA, Elder DE, Stewart R, Damjanovich L, Herlyn M, Buck CA: Integrin distribution in malignant melanoma: association of the β3 subunit with tumor progression. Cancer Res 1990, 50:6757-6764
22. Danen EH, Ten Berge PJ, Van Muijen GN, Van't Hof-Grootenboer AE, Brocker EB, Ruiter DJ: Emergence of α5β1 fibronectin-and αvβ3 vitronectin-receptor expression in melanocytic tumour progression. Histopathology 1994, 24:249-256
23. Danen EH, Jansen KF, Van Kraats AA, Cornelissen IM, Ruiter DJ, Van Muijen GN: αv-integrins in human melanoma: gain of αvβ3 and loss of αvβ5 are related to tumor progression in situ but not to metastatic capacity of cell lines in nude mice [published erratum appears in Int J Cancer 1995, 62:365]. Int J Cancer 1995, 61:491-496
24. Natali PG, Nicotra MR, Di Filippo F, Bigotti A: Expression of fibronectin, fibronectin isoforms and integrin receptors in melanocytic lesions. Br J Cancer 1995, 71:1243-1247
25. Hieken TJ, Farolan M, Ronan SG, Shilkaitis A, Wild L, Das Gupta TK: β3 integrin expression in melanoma predicts subsequent metastasis. J Surg Res 1996, 63:169-173
26. Natali PG, Hamby CV, Felding-Habermann B, Liang B, Nicotra MR, Di Filippo F, Giannarelli D, Temponi M, Ferrone S: Clinical significance of αvβ3 integrin and intercellular adhesion molecule-1 expression in cutaneous malignant melanoma lesions. Cancer Res 1997, 57:1554-1560
27. Schadendorf D, Gawlik C, Haney U, Ostmeier H, Suter L, Czarnetzki BM: Tumour progression and metastatic behaviour in vivo correlates with integrin expression on melanocytic tumours. J Pathol 1993, 170:429-434
28. Gehlsen KR, Davis GE, Sriramarao P: Integrin expression in human melanoma cells with differing invasive and metastatic properties. Clin Exp Metastasis 1992, 10:111-120
29. Nip J, Rabbani SA, Shibata HR, Brodt P: Coordinated expression of the vitronectin receptor and the urokinase-type plasminogen activator receptor in metastatic melanoma cells. J Clin Invest 1995, 95:2096-2103
30. Marshall JF, Nesbitt SA, Helfrich MH, Horton MA, Polakova K, Hart IR: Integrin expression in human melanoma cell lines: heterogeneity of vitronectin receptor composition and function. Int J Cancer 1991, 49:924-931
31. Seftor REB, Seftor EA, Gehlsen KR, Stetler-Stevenson WG, Brown PD, Ruoslahti E, Hendrix MJC: Role of the αvβ3 integrin in human melanoma cell invasion. Proc Natl Acad Sci USA 1992, 89:1557-1561
32. Mitjans F, Sander D, Adan J, Sutter A, Martinez JM, Jaggle CS, Moyano JM, Kreysch HG, Piulats J, Goodman SL: An anti-αv-integrin antibody that blocks integrin function inhibits the development of a human melanoma in nude mice. J Cell Sci 1995, 108:2825-2838
33. Felding-Habermann B, Mueller BM, Romerdahl CA, Cheresh DA: Involvement of integrin αV gene expression in human melanoma tumorigenicity. J Clin Invest 1992, 89:2018-2022
34. Montgomery AM, Reisfeld RA, Cheresh DA: Integrin αvβ3 rescues melanoma cells from apoptosis in three-dimensional dermal collagen. Proc Natl Acad Sci USA 1994, 91:8856-8860
35. Danen EH, van Kraats AA, Cornelissen IM, Ruiter DJ, van Muijen GN: Integrin β3 cDNA transfection into a highly metastatic αvβ3-negative human melanoma cell line inhibits invasion and experimental metastasis. Biochem Biophys Res Commun 1996, 226:75-81
36. Boyce ST, Ham R: Cultivation, frozen storage, and clonal growth of human epidermal keratinocytes in serum free medium. J Tissue Culture Methods 1985, 9:83-93
37. Graham FL, Prevec L: Methods for construction of adenovirus vectors. Mol Biotechnol 1995, 3:207-220
38. Brass L, Shatil S, Kunicki T, Bennet J: Effect of calcium on the stability of the platelet membrane glycoprotein IIb/IIIa complex. J Biol Chem 1985, 260:7875-7881
39. Bell E, Sher S, Hull B, Merrill C, Rosen S, Chamson A, Asselineau D, Dubertret L, Coulomb B, Lapiere C, Nusgens B, Neveux Y: The reconstitution of living skin. J Invest Dermatol 1983, 81:2s-10s
40. Asselineau D, Bernard BA, Bailly C, Darmon M: Retinoic acid improves epidermal morphogenesis. Dev Biol 1989, 133:322-335
41. Chen CS, Lyons-Giordano B, Lazarus GS, Jensen PJ. Differential expression of plasminogen activators and their inhibitors in an organotypic skin coculture system. J Cell Sci 1993, 106:45-53
42. Meredith JEJ, Fazeli B, Schwartz MA: The extracellular matrix as a cell survival factor. Mol Biol Cell 1993, 4:953-961
43. Brooks PC, Montgomery AMP, Rosenfeld M, Reisfeld RA, Hu T, Klier G, Cheresh DA: Integrin αvβ3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell 1994, 79: 1157-1164
44. Boudreau N, Sympson CJ, Werb Z, Bissell M: Suppression of ICE and apoptosis in mammary epithelial cells by extracellular matrix. Science 1995, 267:891-893
45. Varner JA, Cheresh DA: Integrins and cancer. Curr Opin Cell Biol 1996, 8:724-730
46. Seftor RE, Seftor EA, Stetler-Stevenson WG, Hendrix MJ: The 72 kd type IV collagenase is modulated via differential expression of αvβ3 and α5β1 integrins during human melanoma cell invasion. Cancer Res 1993, 53:3411-3415
47. Brooks PC, Stromblad S, Sanders LC, von Schalscha TL, Aimes RT, Stetler-Stevenson WG, Quigley JP, Cheresh DA: Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin αvβ3. Cell 1996, 85:683-693
48. Gouon V, Tucker GC, Kraus-Berthier L, Atassi G, Kieffer N: Up-regulated expression of the β3 integrin and the 92-kd gelatinase in human HT-144 melanoma cell tumors grown in nude mice. Int J Cancer 1996, 68:650-662
49. Hillis GS, MacLeod AM: Integrins and disease. Clin Sci 1996, 91:639-650
50. Vuori K, Ruoslahti E: Association of insulin receptor substrate-1 with integrins. Science 1994, 266:1576-1578
51. Schneller M, Vuori K, Ruoslahti E: αvβ3 integrin associates with activated insulin and PDGFβ receptors and potentiates the biological activity of PDGF. EMBO J 1997, 16:5600-5607
52. Boukerche H, Benchaibi M, Berthier-Vergnes O, Lizard G, Bailly M, Bailly M, McGregor JL: Two human melanoma cell-line variants with enhanced in vivo tumor growth and metastatic capacity do not express the β3 integrin subunit. Eur J Biochem 1994, 220:485-491
53. Shih I-M, Speicher DW, Hsu M-Y, Levine E, Herlyn M: Melanoma cell-cell interactions are mediated through heterophilic Mel-CAM/ ligand adhesion. Cancer Res 1997, 57:3835-3840
54. Deryugina EL, Bourdon MA, Luo G-X, Reisfeld RA, Strongin A: Matrix metalloproteinase-2 activation modulates glioma cell migration. J Cell Sci 1997, 110:2473-2482